esmolol has been researched along with Injury, Myocardial Reperfusion in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (4.35) | 18.7374 |
1990's | 7 (30.43) | 18.2507 |
2000's | 10 (43.48) | 29.6817 |
2010's | 5 (21.74) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, KH; Chan, MY; Fujise, K; Huang, MH; Lee, CH; Low, AF; Lui, CY; Nguyen, V; Poh, KK; Sia, W; Tan, HC; Tang, LQ; Tay, EL; Xu, X | 1 |
Buchholz, B; Del Mauro, JS; Deutsch, ACR; Donato, M; Gelpi, RJ; Höcht, C; Perez, V; Rodríguez, M | 1 |
Huang, MH; Lui, CY; Poh, KK; Tan, HC; Welt, FG | 1 |
Fujise, K; Huang, MH; McConnell, BK; Nguyen, V; Poh, KK; Rastogi, S; Tan, HC; Uretsky, BF; Wijaya, C; Wu, Y | 1 |
Chambers, DJ; Fujii, M | 1 |
McCully, JD | 1 |
Bessho, R; Chambers, DJ | 2 |
Geissler, HJ | 1 |
Fujita, S; Kanaya, N; Kurosawa, S; Nakayama, M; Namiki, A; Niiyama, Y | 1 |
Arora, N; Bhattacharjee, J; Chaudhary, M; Daga, MK; Ghambhir, DS; Sharma, B; Sudha, R | 1 |
Andreadou, I; Bofilis, E; Cokkinos, P; Iliodromitis, EK; Kremastinos, DT; Tasouli, A; Zoga, A | 1 |
Gazmuri, RJ; Noc, M; Sun, S; Tang, W; Weil, MH; Yang, L | 1 |
Guarnieri, C; Matos, G; Papp, B; Röth, E; Varga, J | 1 |
Adams, DL; Allen, SJ; Davis, KL; Gogola, GR; Mehlhorn, U; Warters, RD | 1 |
Deslauriers, R; Ede, M; Gregorash, L; LeHouerou, D; Lessana, A; Pargaonkar, S; Salerno, TA; Summers, R; Ye, J | 1 |
Mehlhorn, U | 1 |
Mehlhorn, U; Südkamp, M | 1 |
Clemens, RM; de Vivie, ER; Geissler, HJ; Hekmat, K; Kuhn-Régnier, F; Mehlhorn, U | 1 |
Addicks, K; Bloch, W; de Vivie, ER; Geissler, HJ; Hekmat, K; Krahwinkel, A; LaRose, K; Mehlhorn, U | 1 |
Allen, SJ; Brennan, ML; Buja, LM; Davis, KL; Geissler, HJ; Laine, GA; Mehlhorn, U | 1 |
De Vivie, ER; Geissler, HJ; Kuhn-Régnier, F; Marohl, S; Mehlhorn, U | 1 |
Kloner, RA; Przyklenk, K | 1 |
1 review(s) available for esmolol and Injury, Myocardial Reperfusion
Article | Year |
---|---|
Therapeutic synergy and complementarity for ischemia/reperfusion injury: β1-adrenergic blockade and phosphodiesterase-3 inhibition.
Topics: Adrenergic beta-1 Receptor Antagonists; Clinical Trials as Topic; Drug Synergism; Humans; Myocardial Reperfusion Injury; Phosphodiesterase 3 Inhibitors; Propanolamines; Signal Transduction; Treatment Outcome | 2016 |
4 trial(s) available for esmolol and Injury, Myocardial Reperfusion
Article | Year |
---|---|
Safety of combination therapy with milrinone and esmolol for heart protection during percutaneous coronary intervention in acute myocardial infarction.
Topics: Blood Pressure; Drug Therapy, Combination; Electrocardiography; Heart Rate; Humans; Infusions, Intravenous; Milrinone; Myocardial Infarction; Myocardial Reperfusion Injury; Percutaneous Coronary Intervention; Propanolamines | 2014 |
Effect of esmolol on oxidant status and antioxidant activity in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Adult; Antioxidants; Double-Blind Method; Female; Free Radicals; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Oxidants; Propanolamines; Prospective Studies | 2003 |
Improved myocardial protection using continuous coronary perfusion with normothermic blood and beta-blockade with esmolol.
Topics: Adrenergic beta-Antagonists; Animals; Cardioplegic Solutions; Coronary Artery Bypass; Coronary Disease; Disease Models, Animal; Dogs; Edema, Cardiac; Female; Heart Arrest, Induced; Heart-Assist Devices; Humans; Male; Myocardial Reperfusion Injury; Propanolamines; Temperature; Ventricular Function, Left | 1997 |
Activation of myocardial constitutive nitric oxide synthase during coronary artery surgery.
Topics: Adrenergic beta-Antagonists; Aged; Coronary Artery Bypass; Heart Arrest, Induced; Humans; Middle Aged; Myocardial Reperfusion Injury; Myocardium; Nerve Tissue Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Propanolamines | 2000 |
18 other study(ies) available for esmolol and Injury, Myocardial Reperfusion
Article | Year |
---|---|
Changes in the loading conditions induced by vagal stimulation modify the myocardial infarct size through sympathetic-parasympathetic interactions.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Atropine; Catecholamines; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hemodynamics; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Propanolamines; Proto-Oncogene Proteins c-akt; Rabbits; Reflex; Signal Transduction; Sympathetic Nervous System; Vagus Nerve | 2015 |
Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusion.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Apoptosis; Cardiotonic Agents; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; In Situ Nick-End Labeling; Infusions, Intravenous; Milrinone; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Phosphodiesterase 3 Inhibitors; Propanolamines; Rats | 2011 |
Cardioprotection with esmolol cardioplegia: efficacy as a blood-based solution.
Topics: Animals; Cardioplegic Solutions; Cardiotonic Agents; Heart; Heart Arrest, Induced; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Propanolamines; Random Allocation; Rats; Rats, Wistar; Ventricular Function, Left | 2013 |
Oxygenated multidose delivery of crystalloid esmolol cardioplegia as an alternative to high potassium cardioplegia.
Topics: Adrenergic beta-Antagonists; Animals; Cardioplegic Solutions; Heart Arrest, Induced; Humans; Myocardial Reperfusion Injury; Oxygen; Potassium Chloride; Propanolamines; Rats | 2002 |
Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Bicarbonates; Cardioplegic Solutions; Heart Arrest, Induced; Male; Myocardial Reperfusion Injury; Oxygen; Potassium Chloride; Propanolamines; Rats; Rats, Wistar; Sodium Chloride | 2002 |
Reduction of myocardial reperfusion injury by high-dose beta-blockade with esmolol.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Cardiopulmonary Bypass; Dogs; Dose-Response Relationship, Drug; Edema, Cardiac; Heart Arrest, Induced; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Propanolamines; Ventricular Function, Left | 2002 |
Landiolol, esmolol and propranolol protect from ischemia/reperfusion injury in isolated guinea pig hearts.
Topics: Adrenergic beta-Antagonists; Animals; Guinea Pigs; Heart; In Vitro Techniques; Male; Morpholines; Myocardial Reperfusion Injury; Propanolamines; Propranolol; Time Factors; Urea; Ventricular Function, Left | 2003 |
Intravenous atenolol and esmolol maintain the protective effect of ischemic preconditioning in vivo.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Hemodynamics; Infusions, Intravenous; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Propanolamines; Rabbits; Survival Rate; Time Factors | 2004 |
Epinephrine increases the severity of postresuscitation myocardial dysfunction.
Topics: Adrenergic Agonists; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Cardiopulmonary Resuscitation; Drug Therapy, Combination; Electric Countershock; Epinephrine; Myocardial Contraction; Myocardial Reperfusion Injury; Phenylephrine; Propanolamines; Rats; Time Factors; Ventricular Fibrillation | 1995 |
Influence of the beta-blocker therapy on neutrophil superoxide generation and platelet aggregation in experimental myocardial ischemia and reflow.
Topics: Adrenergic beta-Antagonists; Animals; Dogs; Female; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Neutrophils; Platelet Aggregation; Propanolamines; Superoxides; Tetradecanoylphorbol Acetate | 1995 |
Cardiac surgical conditions induced by beta-blockade: effect on myocardial fluid balance.
Topics: Adrenergic beta-Antagonists; Animals; Body Water; Cardiopulmonary Bypass; Dogs; Edema; Female; Heart Arrest, Induced; Heart Rate; Heart-Assist Devices; Lymph; Lymphatic System; Male; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Propanolamines; Ventricular Function, Left; Water-Electrolyte Balance | 1996 |
Beyond hyperkalemia: beta-blocker-induced cardiac arrest for normothermic cardiac operations.
Topics: Adrenergic beta-Antagonists; Animals; Blood; Cardioplegic Solutions; Dose-Response Relationship, Drug; Extracorporeal Circulation; Female; Glucose; Heart Arrest, Induced; Male; Myocardial Reperfusion Injury; Potassium; Propanolamines; Rabbits; Rats; Rats, Sprague-Dawley; Swine; Time Factors; Tromethamine | 1997 |
Beta-blockade as an alternative to cardioplegia.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Artery Bypass; Dogs; Echocardiography, Transesophageal; Heart Arrest, Induced; Humans; Myocardial Contraction; Myocardial Reperfusion Injury; Propanolamines; Randomized Controlled Trials as Topic | 1998 |
Emergency coronary artery surgery after failed PTCA: myocardial protection with continuous coronary perfusion of beta-blocker-enriched blood.
Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Blood; Cardioplegic Solutions; Coronary Artery Bypass; Crystalloid Solutions; Emergencies; Female; Heart Arrest, Induced; Hospital Mortality; Humans; Intra-Aortic Balloon Pumping; Isotonic Solutions; Male; Middle Aged; Myocardial Reperfusion Injury; Perfusion; Plasma Substitutes; Propanolamines; Retrospective Studies; Treatment Failure | 1998 |
Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
Topics: Adrenergic beta-Antagonists; Animals; Bicarbonates; Calcium Chloride; Cardioplegic Solutions; Constriction; Heart Arrest, Induced; Magnesium; Male; Myocardial Reperfusion Injury; Perfusion; Potassium Chloride; Propanolamines; Rats; Rats, Wistar; Sodium Chloride; Time Factors; Ventricular Fibrillation | 2001 |
Esmolol and cardiopulmonary bypass during reperfusion reduce myocardial infarct size in dogs.
Topics: Adrenergic beta-Antagonists; Animals; Biopsy; Cardiopulmonary Bypass; Dogs; Female; Male; Microscopy, Electron; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Propanolamines | 2001 |
Beta-blockade in 200 coronary bypass grafting procedures.
Topics: Adrenergic beta-Antagonists; Cardiopulmonary Bypass; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Myocardial Reperfusion Injury; Propanolamines | 2002 |
Is "stunned myocardium" a protective mechanism? Effect of acute recruitment and acute beta-blockade on recovery of contractile function and high-energy phosphate stores at 1 day post-reperfusion.
Topics: Adenosine Triphosphate; Adrenergic beta-Antagonists; Animals; Dogs; Echocardiography; Female; Hydralazine; Male; Myocardial Contraction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Oxygen Consumption; Propanolamines; Stroke Volume; Time Factors | 1989 |